GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a common and highly aggressive type of lymphoma. Iron metabolism plays a critical role in human diseases, however, which remains unclear in DLBCL patients. The study is to explore the genetic characteristics and molecular mechanisms underlying ferroptosis in...
Saved in:
| Main Authors: | Zhang Yuxin, Wang Yue, Wang Shifen, Cui Dawei, Wei Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-05-01
|
| Series: | Open Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/med-2025-1185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy
by: Chaofeng Zhang, et al.
Published: (2024-11-01) -
PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway
by: Chuanming Lin, et al.
Published: (2025-04-01) -
Identification of M2 macrophage-related genes associated with diffuse large B-cell lymphoma via bioinformatics and machine learning approaches
by: Jiayi Zhang, et al.
Published: (2025-04-01) -
CD20 targeted nanomedicine for GCB-diffuse large B-cell lymphoma through synergistic effects of apoptosis and ferroptosis
by: Shu-xian Liu, et al.
Published: (2025-06-01) -
Testicular diffuse large B-cell lymphoma. Clinical lecture and case report
by: K. B. Lelyavin, et al.
Published: (2023-12-01)